Stay updated with breaking news from Marcd Breton. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An artificial pancreas developed at the University of Virginia Center for Diabetes Technology improves blood sugar control for people ages 2 to 72 with type 1 diabetes, according to a new combined analysis of three clinical trials.
According to a new study, an artificial pancreas created at the University of Virginia Center for Diabetes Technologies improves blood sugar management in children aged 2 to 6 with type 1 diabetes
In what is believed to be the first study of its kind, new UVA Health research reveals that a factory-calibrated continuous glucose monitor (CGM) may be sufficiently accurate for use by people on dialysis, a group often plagued by dangerous swings in
In what is believed to be the first study of its kind, new UVA Health research reveals that a factory-calibrated continuous glucose monitor (CGM) may be sufficiently accurate for use by people on dialysis, a group often plagued by dangerous swings in blood-sugar levels.